Outcomes by CCyR and therapy. (A) EFS by therapy among patients with CCyR at 6 months. (B) OS by therapy among patients with CCyR at 6 months. (C) EFS by therapy among patients with CCyR at 12 months. (D) OS by therapy among patients with CCyR at 12 months. (E) Transformation-free survival by therapy (intent-to-treat analysis). (F) Transformation-free survival by therapy among patients with CCyR at 12 months.